1 1

Jakavi 10 mg (Ruxolitinib)

Jakavi 10 mg (Ruxolitinib)

Brand Name: Jakavi
Origin: Switzerland / manufacturing origin may vary by market
Small Orders: Available/YES
Tags: 10mg Tablet , Blood Disorder Treatment , Cancer Medicine , Graft Versus Host Disease , GVHD Treatment , JAK inhibitor , JAK1 Inhibitor , JAK2 Inhibitor , Jakavi 10mg , Jakavi Tablet , Myelofibrosis Treatment , Novartis , Oncology Medicine , Polycythemia Vera Treatment , Prescription Medicine , Ruxolitinib , Ruxolitinib 10mg , Targeted Therapy
Ver todos los detalles
  • Details
  • Description
Packaging Size: 56 tablets per pack in the EU presentation
Strength: 10 mg
Composition: Ruxolitinib 10 mg (as ruxolitinib phosphate) per tablet
Treatment: Myelofibrosis, polycythemia vera, and graft-versus-host disease (GVHD), according to the applicable indication.
Form: Tablet
Brand: Jakavi
Quantity Unit: 1 tablet
Manufacturer: Novartis AG; in Bangladesh, listed through Nevian Lifescience PLC

Jakavi 10 mg (Ruxolitinib) is a prescription medicine used to treat myelofibrosis, polycythemia vera, and certain cases of graft-versus-host disease (GVHD). It works by inhibiting JAK1 and JAK2 enzymes, helping control abnormal blood-cell production, reduce spleen enlargement, and relieve disease-related symptoms. It is used under medical supervision with regular blood-count monitoring.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.